Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 11 317,64 kr, with a 24-hour trading volume of 0 kr. The asset's market cap is 10,09T kr, after moving 1.08% in the last day.
Tokenized Eli Lilly And Co is trading at 11 321,7 kr, with a tokenized market cap of 440,66M kr and a 24-hour trading volume of 20,82M kr. The tokenized asset has moved 0.60% in the past 24 hours.